Search research articles
Contact Us
Filters
Showing results (91-100 of 111) with videos related to
Page
of 12
Sort By:
Cell Reports
|
September 29, 2015
APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer
Manikandan Periyasamy, Hetal Patel, Chun-Fui Lai, et al.
Nature Communications
|
July 24, 2023
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib
R C Coombes, Sacha Howell, Simon R Lord, et al.
Nature Communications
|
March 6, 2025
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib
R C Coombes, Sacha Howell, Simon R Lord, et al.
JCO Precision Oncology
|
December 1, 2021
Circulating Tumor DNA Profiling From Breast Cancer Screening Through to Metastatic Disease
Karen Page, Luke J Martinson, Daniel Fernandez-Garcia, et al.
Nature Communications
|
August 7, 2023
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib
R C Coombes, Sacha Howell, Simon R Lord, et al.
Oncogene
|
October 5, 2022
Genome engineering for estrogen receptor mutations reveals differential responses to anti-estrogens and new prognostic gene signatures for breast cancer
Alison Harrod, Chun-Fui Lai, Isabella Goldsbrough, et al.
Research Square
|
March 18, 2024
Differentiation signals induce <i>APOBEC3A</i> expression via GRHL3 in squamous epithelia and squamous cell carcinoma
Nicola J Smith, Ian Reddin, Paige Policelli, et al.
The EMBO Journal
|
November 15, 2024
Differentiation signals induce APOBEC3A expression via GRHL3 in squamous epithelia and squamous cell carcinoma
Nicola J Smith, Ian Reddin, Paige Policelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 16, 2016
Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor-Positive Breast Cancer
Hetal Patel, Rezvan Abduljabbar, Chun-Fui Lai, et al.
Cancer Research
|
October 2, 2024
Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor-Targeted Therapy Drives Resistance in Breast Cancer
Carolina Gemma, Chun-Fui Lai, Anup K Singh, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 111) with videos related to
Sort By:
Page
of 12
Cell Reports
|
September 29, 2015
APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer
Manikandan Periyasamy, Hetal Patel, Chun-Fui Lai, et al.
Nature Communications
|
July 24, 2023
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib
R C Coombes, Sacha Howell, Simon R Lord, et al.
Nature Communications
|
March 6, 2025
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib
R C Coombes, Sacha Howell, Simon R Lord, et al.
JCO Precision Oncology
|
December 1, 2021
Circulating Tumor DNA Profiling From Breast Cancer Screening Through to Metastatic Disease
Karen Page, Luke J Martinson, Daniel Fernandez-Garcia, et al.
Nature Communications
|
August 7, 2023
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib
R C Coombes, Sacha Howell, Simon R Lord, et al.
Oncogene
|
October 5, 2022
Genome engineering for estrogen receptor mutations reveals differential responses to anti-estrogens and new prognostic gene signatures for breast cancer
Alison Harrod, Chun-Fui Lai, Isabella Goldsbrough, et al.
Research Square
|
March 18, 2024
Differentiation signals induce <i>APOBEC3A</i> expression via GRHL3 in squamous epithelia and squamous cell carcinoma
Nicola J Smith, Ian Reddin, Paige Policelli, et al.
The EMBO Journal
|
November 15, 2024
Differentiation signals induce APOBEC3A expression via GRHL3 in squamous epithelia and squamous cell carcinoma
Nicola J Smith, Ian Reddin, Paige Policelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 16, 2016
Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor-Positive Breast Cancer
Hetal Patel, Rezvan Abduljabbar, Chun-Fui Lai, et al.
Cancer Research
|
October 2, 2024
Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor-Targeted Therapy Drives Resistance in Breast Cancer
Carolina Gemma, Chun-Fui Lai, Anup K Singh, et al.
Page
of 12